Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
190 Volume Outcome <strong>KCE</strong> reports 113<br />
Volume treated<br />
350<br />
300<br />
250<br />
200<br />
150<br />
100<br />
50<br />
0<br />
Figure 7.9: Total knee arthr<strong>op</strong>lasty: <strong>volume</strong> per surgeon<br />
7.2.5 Definition of outcomes<br />
Common outcome measures are mortality, loss of in<strong>de</strong>p<strong>en</strong>d<strong>en</strong>ce, loss of mobility and<br />
residual pain. Unfortunately, the latter three are not registered in the MCD.<br />
Complications associated with TKR can be divi<strong>de</strong>d in three kinds. Those associated with<br />
the risk of anaesthesia inclu<strong>de</strong>s acute myocardial infarction. Those associated with<br />
immobilization inclu<strong>de</strong> <strong>de</strong>vel<strong>op</strong>m<strong>en</strong>t of <strong>de</strong>ep vein thrombosis, pulmonary embolism,<br />
pneumonia, and muscular atr<strong>op</strong>hy; those associated with the surgical procedure inclu<strong>de</strong><br />
post<strong>op</strong>erative infection, mechanical malfunctions of the prosthesis and dislocation of the<br />
knee joint. These complications can give cause for a re-interv<strong>en</strong>tion, i.e. a revision knee<br />
replacem<strong>en</strong>t. Finally, in the long term, there is the problem of knee replacem<strong>en</strong>ts<br />
progressively wearing out over the years. Pati<strong>en</strong>ts who wear out their prosthesis will<br />
require a revision knee replacem<strong>en</strong>t surgery.<br />
The literature review (see Table 2.1 on page 16) id<strong>en</strong>tified the following outcome<br />
measures for TKR: in-hospital mortality, in-hospital complication rate, 90-day<br />
complication rate and the 90-day revision rate. The revision rate was also studied at 36<br />
months, but since MCD data were only available for 2004 and 2005, this long-term<br />
outcome measure was not retained in our analyses. 62<br />
7.2.5.1 In-hospital outcome<br />
In-hospital outcome inclu<strong>de</strong>s in-hospital mortality as well as complications after total<br />
knee arthr<strong>op</strong>lasty. Information on in-hospital complications was retrieved from the<br />
MCD, on the basis of the following ICD-9-CM secondary diagnosis co<strong>de</strong>s during in<strong>de</strong>x<br />
admission: 310<br />
• Deep wound infection (SSI): 996.66 “Infection and inflammatory reaction<br />
due to internal joint prosthesis”<br />
• Pulmonary embolism: 415.1 “Pulmonary embolism and infarction”<br />
• Deep v<strong>en</strong>ous thrombosis (DVT): 451.1x “Phlebitis and thromb<strong>op</strong>hlebitis<br />
of <strong>de</strong>ep vessels of lower extremities”.<br />
Table 7.25 shows that these four outcome measures are rare ev<strong>en</strong>ts. During the 11 017<br />
elective TKR stays, 17 pati<strong>en</strong>ts <strong>de</strong>ceased during their hospitalization. The most frequ<strong>en</strong>t<br />
in-hospital complication was pulmonary embolism with 0.46% (0.34%, 0.61%). Similarly<br />
to what was done for total hip arthr<strong>op</strong>lasty, no further analysis in terms of VOA was<br />
performed on in-hospital outcomes. Instead, all our att<strong>en</strong>tion was focused on ev<strong>en</strong>ts<br />
occurring within 90 days after the first in<strong>de</strong>x stay, and on the revision rate at 12<br />
months.